August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Haystack MRD by Quest Diagnostics Received FDA Breakthrough Device Designation
Aug 26, 2025, 15:45

Haystack MRD by Quest Diagnostics Received FDA Breakthrough Device Designation

Svetlana Nikic, Founder at Precision Oncology Consulting, shared a post by Frank Holtrup, Chief Technology Officer at Haystack Oncology, on LinkedIn, adding:

“Congratulations Haystack team, a Quest Diagnostics company for receiving breakthrough device designation by FDA for their MRD assay (aimed for use for stage II CRC patients).”

Quoting Frank Holtrup‘s post:

“Proud of the entire Haystack MRD™ by Quest Diagnostics® team for achieving this important milestone on our way to create a healthier world, one life at a time.”

More posts featuring Svetlana Nikic.